Crystal Nyitray is the Founder and CEO of Encellin. She is an alum of UCSF, Sanofi, and Y Combinator. She led Encellin’s >$5M seed raise, authored over 10 patents, and is an awardee of MedTech Innovator, Rosenman Innovators, and American Diabetes Innovator. Crystal joined the first cohort of UCSF Rosenman RISE founders in 2022.
